Federal contract award
75F40124F19004
5-YEAR T&M TASK ORDER FOR TRANSLATION AND TRANSCRIPTION SERVICES TO SUPPORT THE FDA'S CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF COMMUNICATIONS (OCOMM)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541930 — Translation and Interpretation Services |
| PSC | R499 — Other Professional Services |
| Parent award / vehicle | 75F40123D00005 |
| Set-aside | Not reported |
| Pricing type | TIME AND MATERIALS |
| Obligations | $133.9K |
| Current contract value | $133.9K |
| Potential contract value / ceiling | $236.1K |
| Start date | Jan 17, 2024 |
| Current end date | Jul 30, 2026 |
| Potential end date | Mar 1, 2029 |
| Latest award activity | Jul 30, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 30, 2026 | P00004 | $49.1K | T&M-TYPE TASK ORDER FOR TRANSLATION AND TRANSCRIPTION SERVICES TO SUPPORT THE FDA'S CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF COMMUNICATIONS (OCOMM). |
| Jan 28, 2026 | P00003 | $-9.0K | T&M-TYPE TASK ORDER FOR TRANSLATION AND TRANSCRIPTION SERVICES TO SUPPORT THE FDA'S CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF COMMUNICATIONS (OCOMM). |
| Jun 13, 2025 | P00002 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO CHANGE THE CONTRACTING OFFICER'S REPRESENTATIVE (COR) FROM DIONNE BROWN TO WILLIAM LEE. |
| Nov 15, 2024 | P00001 | $47.6K | 5-YEAR T&M TASK ORDER FOR TRANSLATION AND TRANSCRIPTION SERVICES TO SUPPORT THE FDA'S CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF COMMUNICATIONS (OCOMM) |
| Jan 17, 2024 | 0 | $46.1K | 5-YEAR T&M TASK ORDER FOR TRANSLATION AND TRANSCRIPTION SERVICES TO SUPPORT THE FDA'S CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF COMMUNICATIONS (OCOMM) |
Estimated positioning window
Mar 1, 2028 – Sep 1, 2028
55/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 55/100. Available recorded signals: 50 points.
- Contract end 2029-03-01 (858 days from calculation)
- +15 points
- 23 historical awards in this buyer and category group
- +15 points
- 5 recorded award transactions
- +10 points
- Latest award action: 2026-07-30
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.